Trending Topic

Acute myeloid leukaemia
3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

“We are facing an exciting era of fast-paced drug development in acute myeloid leukaemia” writes Gianfranco Bittar and colleagues at Baylor College of Medicine, Houston, TX, USA, in a review published in touchREVIEWS in Oncology & Haematology. In 2020, there were an estimated 21,450 new patients with acute myeloid leukaemia (AML) and 11,180 AML-related deaths […]

2 mins

EHA 2025: The countdown is on!

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: May 14th 2025

The 30th EHA Congress will take place in Milan from 12–15th June 2025 and touchHAEMATOLOGY are thrilled to be attending on site, speaking with leading experts across the field. Keep an eye out on our website and social media for the latest news, updates and Q&As fresh from Milan!

Click here to view the coverage from EHA 2024.

Preview – hot topics

  • Novel RNA biology and epitranscriptomics
  • Transcriptional control in hematopoiesis and hematological malignancies
  • Consequences of mutations in chromatin regulators
  • 3D chromatin architecture and nuclear organization
  • Targeting chromatin regulators in hematology
  • The non-coding genome

Abstracts are available here

The EHA2025 Presidential Session features:

  • Immunotherapy (TCR related) Prof. Johanna Olweus (Norway)
  • Artificial intelligence in hematology: Opportunities, pitfalls and how to bring it to clinical practice Prof. Jakob Nikolas Kather (Germany)
  • From biology to targeted therapies in immune thrombocytopenia Prof. Nichola Cooper (United Kingdom)
  • What makes a stem cell a stem cell Prof. Sten Eirik Jacobsen (Sweden)
  • Genomic profiling of lymphomas Prof. Dan Hodson (United Kingdom)

Hot topics from the plenary sessions:

  • Lymphoid malignancies: plasma cell neoplasms
  • Myeloid malignancies: chronic myeloid neoplasms
  • Treatment: immunotherapy
  • Treatment: transplantation and cellular therapies

The European Hematology Association (EHA) is a leading non-profit organization dedicated to advancing excellence in patient care, research, and education in hematology across Europe and globally. EHA collaborates with national hematology societies to harmonize education and training across Europe. It also partners with international organizations to strengthen the global hematology community.

For more information, visit the official EHA website.

​Disclosure: This article was created by the touchHAEMATOLOGY team utilizing AI as an editorial tool (ChatGPT (GPT-4o) [Large language model]. https://chat.openai.com/chat.) The content was developed and edited by human editors. No funding was received in the publication of this article.

SIGN UP to touchHAEMATOLOGY!

Join our global community today for access to thousands of peer-reviewed articles, expert insights, and learn-on-the-go education across 150+ specialties, plus concise email updates and newsletters so you never miss out.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup